IVD Directive Deadline Looms Large For Inadequately Prepared Firms – Survey
This article was originally published in The Gray Sheet
Executive Summary
Many U.S. manufacturers seeking a CE mark for in vitro diagnostic products in the EU lack effective plans for complying with the Dec. 7, 2003 IVD Directive deadline and risk losing revenue and market share, according to industry analysts
You may also be interested in...
In-House IVD Manufacturers Get Extra Time To Comply With IVD Directive
UK health institutions that manufacture in vitro diagnostics "in-house" and are subject to the IVD Directive will have until the end of 2005 to come into compliance with directive requirements
In-House IVD Manufacturers Get Extra Time To Comply With IVD Directive
UK health institutions that manufacture in vitro diagnostics "in-house" and are subject to the IVD Directive will have until the end of 2005 to come into compliance with directive requirements
EU Enlargement Broadens IVD Directive Electronic Labeling Concerns – EDMA
FDA's interpretation of MDUFMA electronic labeling provisions will be relevant to firms looking to comply with the EU's In Vitro Diagnostics Directive, European Diagnostic Manufacturers Association (EDMA) Director General Christine Tarrajat observed April 9